| Amy Francine Chevrefils, MS CCC SLP | |
|
2 Whitney Rd, Concord, NH 03301-1844 | |
| (603) 226-3212 | |
| (603) 225-0376 |
| Full Name | Amy Francine Chevrefils |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2 Whitney Rd, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710119862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1254 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Francine Chevrefils, MS CCC SLP 2 Whitney Rd, Concord, NH 03301-1844 Ph: (603) 226-3212 | Amy Francine Chevrefils, MS CCC SLP 2 Whitney Rd, Concord, NH 03301-1844 Ph: (603) 226-3212 |
News Archive
Dartmouth researchers have found that reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the IGF-1 receptor.
Researchers at The University of Texas Health Science Center at Houston are helping to make precision medicine a reality by sequencing entire exomes of people to assess chronic disease risk and drug efficacy. The results of a study on this topic were published in Nature Genetics on Monday.
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
"Africa has the highest maternal mortality rates in the world, with 48 percent of all global maternal deaths occurring in this region," Jotham Musinguzi, regional director of the Partners in Population and Development Africa Regional Office in Kampala, Uganda, writes in an Independent opinion piece.
The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications – Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant.
› Verified 2 days ago
Nicole Mcaree, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 404, Concord, NH 03301 Phone: 603-228-7827 | |
Ms. Laura A Darling, M.S.CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Bridge St Ste 1a, Concord, NH 03301 Phone: 603-224-1551 Fax: 603-224-1330 | |
Christopher Paul Doherty, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 144 South St, Concord, NH 03301 Phone: 603-225-0862 | |
Patricia Morrell, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 152 South St, Concord, NH 03301 Phone: 603-225-0827 | |
Ms. Wanda Moulton Denoncour, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 Sewalls Falls Rd, Concord, NH 03301 Phone: 603-225-0853 | |
Mrs. Andrea Parker, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Fisherville Rd Unit 20, Concord, NH 03303 Phone: 603-410-7577 | |
Elizabeth Sirois, SLP-CFY/NH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 239 Pleasant St, Pleasant View Center, Concord, NH 03301 Phone: 603-224-6561 |